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Abstract: Polybrominated diphenyl ethers (PBDEs) are widely used flame 
retardants; currently, they are identified as ubiquitous environmental contaminants. 
Several studies indicate that PBDEs might affect male fertility. We present the 
results of a pilot study on the relationship between human serum PBDEs and 
sperm quality. The PBDE levels in Japan are comparable to those found in 
European countries. Strong inverse correlations were observed between the serum 
concentration of 2,2′,4,4′,5,5′-hexabromodiphenyl ether and sperm concentration 
(r = –0.841, p = 0.002) and testis size (r = –0.764, p = 0.01). Extensive studies on 
the relationship between PBDEs and sperm quality are required. 
 
Keywords: polybrominated diphenyl ethers; flame retardants; human serum; 
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Polybrominated diphenyl ethers (PBDEs) are used as flame retardants in the 
production of common consumer products such as electronics, furniture, and 
textiles. PBDEs are currently recognized as environmental pollutants of global 
concern because their levels in the environment and in humans have increased 
markedly over the past several decades (Meironyté et al., 1999; Ikonomou et al., 
2002; Akutsu et al., 2003). Since PBDEs are somewhat structurally similar to 
thyroid hormones such as thyroxine (T4), it was speculated that PBDEs might 
mimic thyroid hormones and disrupt thyroid homeostasis. Several studies indicate 
that exposure to PBDEs can decrease the circulating levels of T4 in laboratory 
animals (Fowles et al., 1994; Zhou et al., 2002) and can cause permanent 
neurological effects similar to those associated with thyroid hormone deficiencies 
(Eriksson et al., 2001; Viberg et al., 2004). In addition, several PBDEs possess 
weak estrogenic/antiestrogenic activities (Meerts et al., 2001). The proliferation 
and differentiation of Sertoli cells and sperm production are regulated by thyroid 
and sex hormones. Thus, PBDEs might affect male reproductive health by 
interfering with the thyroid- and sex-hormone functions. Kuriyama et al. (2005) 
have reported that developmental exposure to a single low dose (60 µg/kg body 
weight) of 2,2′,4,4′,5-pentabromodiphenyl ether (PeBDE-99) decreased the sperm 
count in male Wistar rats. However, no previous studies have examined the 
relationship between human PBDE levels and sperm quality. 
 
We participated in an international project examining the sperm quality of fertile 
males and found that the sperm concentration of Japanese males was lower than 
that of European males (Iwamoto et al., 2006). The examination of sperm quality 
and an estimation of the concentration of chemicals in the serum would be 
required to reveal the correlation between chemical exposure and the sperm 
quality in Japanese males. The aim of this pilot study was to measure PBDEs in 
serum samples from young Japanese males and to examine the relationship 
between serum PBDE levels and sperm quality. 
 
MATERIALS AND METHODS 
This study was performed in accordance with the protocols which were approved 
by the ethical committees of the St. Marianna University School of Medicine and 
Osaka Prefectural Institute of Public Health. Written informed consent was 
obtained from all study participants. Blood serum and sperm samples were 
collected on a monthly basis in the year 2003 from 45 young Japanese males at 
the Department of Urology, St. Marianna University School of Medicine. The 
participants were instructed to abstain from ejaculation for at least 48 h prior to 
sperm collection. The blood samples were collected in vacuum tubes, and the 
serum fractions were separated by centrifugation. The serum samples were stored 
at –80°C until analysis. Of the 45 sample sets, 10 were randomly selected for this 
study. For PBDE analysis, 10 pooled serum samples (0.5 g × 12 months; total, 6 g 
per person) were prepared, and each pool was regarded as a representative sample 
of each set. The mean ± standard deviation (SD) of the age of the 10 participants 
was 22 ± 1 years (range, 18–22 years). The mean ± SD abstinence period was 3.1 
















































human serum (“L-Consera N” and “L-Suitrol I,” Nissui Pharmaceutical, Tokyo, 
Japan) were used as in-house reference materials. 
 
Standard mixture solutions of native PBDEs (BDE-AAP-A-15X) were purchased 
from AccuStandard (New Haven, CT, USA), and 13C12-labeled PBDEs (MBDE-
MXC) were purchased from Wellington Laboratories (Ontario, Canada). In this 
study, 29 PBDE congeners with 3 to 7 bromine atoms were monitored. The PBDE 
numbers are assigned according to the International Union of Pure and Applied 
Chemistry nomenclature for polychlorinated biphenyls. Acetone, acetonitrile, and 
n-hexane of pesticide analysis grade; ammonium sulfate of biochemistry grade; 
44% sulfuric acid-impregnated silica gel; and n-nonane of dioxin analysis grade 
were purchased from Wako Pure Chemical Industries (Osaka, Japan). Water was 
deionized and purified using a Milli-Q cartridge system (Millipore, Bedford, MA, 
USA). 
 
Sperm analyses were performed at the Department of Urology, St. Marianna 
University School of Medicine, according to World Health Organization criteria 
as described elsewhere (World Health Organization, 1999; Iwamoto et al., 2006).  
 
Serum samples were analyzed at Osaka Prefectural Institute of Public Health. The 
serum sample (6 g) was extracted using ethanol/n-hexane (1:3 v/v, 14 mL) in a 50 
mL test tube after adding 13C12-labeled surrogate standards (13C12-2,4,4′-
tribromodiphenyl ether (13 13C12-TrBDE-28), C12-2,2′,4,4′-tetrabromodiphenyl 
ether (13 13 13C12-TeBDE-47), C12-2,2′,4,4′,5-pentabromodiphenyl ether ( C12-
PeBDE-99), 13C12-2,2′,4,4′,5,5′-hexabromodiphenyl ether (13C12-HxBDE-153), 
13 13C12-2,2′,4,4′,5,6′-HxBDE ( C12-HxBDE-154), and 13C12-2,2′,3,4,4′,5′,6-
heptabromodiphenyl ether (13C12-HpBDE-183); 10 pg for each congener) and 3.6 
mL saturated ammonium sulfate solution. The test tube was shaken for 30 min 
and then centrifuged for 10 min at 3000 rpm. The n-hexane phase was collected, 
and the aqueous phase was re-extracted twice with 12 mL n-hexane. The 3 n-
hexane phases were combined and washed with 12 mL water. After evaporation 
of the solvent, the lipid content was determined gravimetrically using a semimicro 
balance (Sartorius RC210P, Goettingen, Germany). The lipid was dissolved in n-
hexane and transferred to a column of 44% sulfuric acid-impregnated silica gel (3 
g). The column was eluted with 30 mL n-hexane, and the eluate was evaporated to 
2 mL. The n-hexane solution was transferred to a test tube and partitioned with n-
hexane-saturated acetonitrile (4 mL) 3 times by shaking the test tube for 10 min 
and then centrifuging for 10 min at 3000 rpm. The acetonitrile phase was 
combined and then evaporated to dryness. The residue was redissolved in n-
hexane and transferred to a microconcentration tube. After addition of the 
injection standard (13 13C12-3,3′,4,4′,5-PeBDE ( C12-PeBDE-126)) and keeper 
solvent (10 µL n-nonane), the extract was finally evaporated to approximately 10 
µL under a gentle stream of nitrogen. The serum extract was assayed by a gas 
chromatography/mass spectrometry (GC/MS) system (Agilent 6890A GC coupled 
with JEOL JMS-GCmateII, Tokyo, Japan) using a fused silica capillary column 
















































PA, USA). For each compound, 2 ions of the molecular ion or fragment ion 
cluster were monitored. Quantitation was based on the isotope dilution method 
using 13C12-labeled internal standards. The PBDE concentrations were adjusted 
for total serum lipids and were expressed in units of nanogram per gram lipid 
weight (ng/g lw). TeBDE-47, PeBDE-99, PeBDE-100, and HxBDE-153 were of 
interest because they are dominant in human serum. 
 
We validated the serum extraction procedure prior to beginning sample analysis 
by analyzing 4 replicate samples of pooled serum fortified with target analytes at 
0.04–0.1 ng/g serum. The mean percent recovery of 7 representative PBDE 
congeners (TrBDE-28, TeBDE-47, PeBDE-99, PeBDE-100, HxBDE-153, 
HxBDE-154, and HpBDE-183) ranged from 91% to 107%, and the relative 
standard deviation (RSD) ranged from 2% to 10%. The limit of detection (LOD) 
and limit of quantification (LOQ) were defined as 3 times and 10 times the SD 
values obtained from the analysis of the 7 procedural blank samples (6 g of water), 
respectively. However, for congeners that could not be detected in the blanks, the 
values that were 3 times and 10 times the SD values obtained from the analysis of 
5 replicates of the lowest calibration standard were used as LOD and LOQ. The 
LOD values for all the PBDE congeners were below 0.3 ng/g lw. In the analysis 
of 3 split unfortified serum samples, the RSD values for all the detected congeners 
were below 10%. 
 
RESULTS AND DISCUSSION 
 
Of the 29 PBDE congeners monitored, 4 congeners (TeBDE-47, PeBDE-99, 
PeBDE-100, and HxBDE-153) were mainly detected in human serum samples 
(Figure 1). The concentrations of the detected PBDE congeners in the serum 
samples (n = 10) are shown in Table 1. The median levels of the individual PBDE 
congeners were as follows: TeBDE-47, 1.4 ng/g lw; PeBDE-99, 0.21 ng/g lw; 
PeBDE-100, 0.24 ng/g lw; and HxBDE-153, 0.72 ng/g lw. The levels of total 
PBDEs in Japanese human serum samples were almost the same as those reported 
in European countries but were 1 order of magnitude lower than those reported in 
USA (Hites, 2004). Significant positive correlations were observed between the 
concentrations of TeBDE-47 and PeBDE-99 (r = 0.988, p < 0.001), TeBDE-47 
and PeBDE-100 (r = 0.938, p < 0.001), and PeBDE-99 and PeBDE-100 (r = 0.915, 
p < 0.001). In contrast, no significant correlations were observed between the 
concentration of HxBDE-153 and those of the other 3 congeners (r = 0.306–0.390, 
p = 0.26–0.39). The absence of a significant correlation between HxBDE-153 and 
the other 3 dominant congeners (TeBDE-47, PeBDE-99, and PeBDE-100) implies 
that the main sources and/or biological properties of HxBDE-153 were different 
from those of the other 3 congeners. It has been reported that the technical 
mixtures of pentaBDE (DE-71 and Bromkal 70-5DE) and octaBDE (DE-79 and 
Bromkal 79-8DE) both contained HxBDE-153 in the range 5.32–5.44% w/w and 
0.15–8.66% w/w, respectively (La Guardia et al., 2006). The congeners TeBDE-
47, PeBDE-99, and PeBDE-100 have been found in pentaBDE as the major 
















































These 3 congeners and HxBDE-153 have never been found in a technical 
decaBDE mixture (Saytex 102E and Bromkal 82-0DE) (La Guardia et al., 2006). 
Therefore, TeBDE-47, PeBDE-99, and PeBDE-100 are mainly sourced from 
pentaBDE, although HxBDE-153 is sourced from both pentaBDE and octaBDE. 
In the early 1990s, Japanese manufacturers voluntarily stopped the production and 
use of pentaBDE because its potency to accumulate in the biota and produce toxic 
polybrominated dibenzofurans/dioxins under thermal stresses was a cause of 
concern. However, the production and use of octaBDE were continued in Japan 
until 2002 (Ministry of the Environment, Japan, 2006). Therefore, many consumer 
products containing octaBDE in the Japanese indoor environment might continue 
to exist. Thus, with regard to octaBDE components such as HxBDE-153 and 
HpBDE-183, inhalation and dermal exposure might be important exposure routes 
for the Japanese people. Geyer et al. (2004) have predicted elimination half-lives 
of PBDEs in the human adipose tissue; the predicted half-lives of individual 
congeners in an adult male were as follows: TeBDE-47, 1.9 years; PeBDE-99, 3.5 
years; PeBDE-100, 2.4 years; and HxBDE-153, 7.8 years. It is expected that the 
half-lives of Te–HxBDEs increase with the number of bromine atoms per 
molecule, and the half-life of HxBDE-153 is much longer than those of other 
dominant congeners detected in human serum. Further research is needed to 
examine the difference between the elimination half-lives and toxicity of 
individual PBDE congeners in animals and humans. 
 
The sperm concentration and testis size of the 10 participants are shown in Table 
2. The sperm concentration of these participants ranged from 25 to 115 
million/mL. No participant had a sperm concentration below 20 million/mL, the 
minimum fertility standard established by the World Health Organization (World 
Health Organization, 1999). Strong inverse correlations were observed between 
the serum HxBDE-153 concentration and sperm concentration (r = –0.841, p = 
0.002; Figure 2) and testis size (r = –0.764, p = 0.01). However, no significant 
relationships were observed between the serum concentrations of the other 
congeners and the sperm concentration (r ranged from –0.187 to –0.099, p = 
0.605–0.786) or testis size (r ranged from –0.216 to –0.054, p = 0.548–0.883). 
Researchers have hypothesized that endocrine-disrupting chemicals with thyroid-
hormonal or sex-hormonal activities might adversely affect male fertility. The 
thyroid-disrupting and estrogenic/antiestrogenic activities of PBDEs have been 
reported in several studies (Meerts et al., 2001; Zhou et al., 2002). In addition, 
considerable evidence regarding the reproductive effects of PBDEs is available 
from in vivo studies. Kuriyama et al. (2005) have reported that developmental 
exposure to a single low dose (60 µg/kg body weight) of PeBDE-99 decreased the 
sperm count in male Wistar rats. Although the levels of PBDEs found in our study 
are relatively low, we observed significant inverse associations between the serum 
concentration of HxBDE-153 and the sperm concentration and testis size; this 
suggests an association between the serum HxBDE-153 concentration and human 
sperm quality. The lack of a significant relationship among other individual PBDE 
congeners and sperm parameters might indicate a difference in bioactivity 
















































complicated problem and needs further study. 
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Figure 1   Chromatograms of PBDEs in human serum (participant No.2) and 
standard solution (1 to 2.5 ng/mL each) 




Table 1   Concentrations of PBDEs in serum samples from 10 Japanese males (ng/g lw)
Participant No.
Congener 1 2 3 4 5 6 7 8 9 10
TrBDE-17 tr <0.04 tr <0.05 nd <0.01 nd <0.01 nd <0.02 nd <0.01 nd <0.02 nd <0.01 nd <0.02 nd <0.02
TrBDE-28/33 tr <0.2 0.37 0.16 tr <0.2 0.16 0.24 tr <0.2 0.17 tr <0.2 tr <0.2
TrBDE-37 tr <0.02 tr <0.03 nd <0.01 nd <0.01 nd <0.01 nd <0.01 nd <0.01 nd <0.01 nd <0.01 nd <0.01
TeBDE-49 nd <0.02 nd <0.03 0.09 tr <0.07 tr <0.08 0.07 nd <0.02 0.09 nd <0.03 tr <0.09
TeBDE-47 1.3 5.9 1.5 0.96 1.6 1.8 0.54 2.9 0.93 0.81
TeBDE-66 nd <0.04 nd <0.05 nd <0.04 nd <0.04 nd <0.04 nd <0.04 nd <0.04 tr <0.2 nd <0.05 nd <0.05
PeBDE-100 0.23 0.67 0.24 0.21 0.24 0.40 0.13 0.31 0.21 0.25
PeBDE-99 0.21 1.1 0.21 0.16 0.25 0.21 0.10 0.49 0.15 0.20
PeBDE-118 0.02 0.03 tr <0.02 tr <0.02 0.02 0.03 tr <0.02 tr <0.02 0.03 0.03
PeBDE-85 tr <0.07 tr <0.09 tr <0.07 nd <0.02 tr <0.08 nd <0.02 nd <0.02 tr <0.07 nd <0.03 nd <0.02
HxBDE-155 nd <0.02 tr <0.07 tr <0.05 tr <0.05 nd <0.02 tr <0.06 nd <0.02 nd <0.02 tr <0.07 nd <0.02
HxBDE-154 tr <0.06 0.08 0.05 0.05 tr <0.06 0.06 tr <0.06 tr <0.06 tr <0.07 tr <0.07
HxBDE-153 0.76 0.96 1.1 0.56 0.58 0.68 0.37 0.52 0.91 0.79
HpBDE-183 nd <0.1 nd <0.2 tr <0.4 tr <0.4 tr <0.4 tr <0.4 nd <0.1 nd <0.1 tr <0.5 nd <0.2
Sum of 4 PBDEsa 2.5 8.6 3.1 1.9 2.7 3.1 1.1 4.2 2.2 2.1
Abbreviations: tr, trace; nd, not detected. aSum of TeBDE-47, PeBDE-100, PeBDE-99, and HxBDE-153.
Table 2    Sperm concentration and testis size of 10 Japanese males
Participant No.
1 2 3 4 5 6 7 8 9 10
Sperm concentration (million/mL)a 49 55 38 108 83 74 115 78 25 30
Testis size (mL)b 36 36 40 50 46 42 51 54 29 33
aAnnual average of monthly data. bTotal of right and left testes.
13C12-TrBDE





















































































Serum HxBDE-153 conc. (ng/g lw)
Fig.2
